---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-097364"
form_type: "8-K12B"
ticker: "SILO"
cik: "0001514183"
company_name: "Silo Pharma, Inc."
filed_at: "2023-12-20T23:59:59+00:00"
generated_at: "2026-06-07T09:48:16.009773+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Silo Pharma reincorporates from Delaware to Nevada, effective December 19, 2023

## Summary
- Reincorporation completed via Plan of Conversion approved by stockholders on Dec 4/11, 2023.
- Each outstanding share of Delaware common stock converted one-for-one into Nevada common stock.
- Options, warrants, and equity plans continue on same terms; no exchange of stock certificates required.
- Ticker remains SILO on Nasdaq; business, management, and offices unchanged.
- Stockholder rights now governed by Nevada law; differences detailed in Oct 23, 2023 proxy statement.

## SEC filing metadata
- accession: 0001213900-23-097364
- form_type: 8-K12B
- ticker: SILO
- cik: 0001514183
- company_name: Silo Pharma, Inc.
- filed_at: 2023-12-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514183/000121390023097364/0001213900-23-097364-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514183/000121390023097364/ea190371-8k12b_silopharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-097364
- JSON: https://secwatch.observer/filing/0001213900-23-097364.json
- Plain text: https://secwatch.observer/filing/0001213900-23-097364.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.